Brief: Immunocore Reports 2022 Financial Results And Provides Business Update

Immunocore Holdings

01/03/2023 15:04

March 1 (Reuters) - Immunocore Holdings Plc  IMCR.O :
    * IMMUNOCORE REPORTS 2022 FINANCIAL RESULTS AND PROVIDES
BUSINESS
UPDATE
    * Q4 LOSS PER SHARE $0.63
    * CASH AND CASH EQUIVALENTS OF $401.6 MILLION AS OF DEC 31,
2022;
CASH RUNWAY INTO 2026 WITH PROJECTED KIMMTRAK REVENUES
    * KIMMTRAK / TEBENTAFUSP NET REVENUES OF $51 MILLION IN Q4
2022
    * Q4 EARNINGS PER SHARE VIEW -0.00 PENCE -- REFINITIV IBES
DATA

Source text for Eikon:  ID:nGNXLr4n4 
Further company coverage:  IMCR.O